We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Allergopharma and S-TARget Conclude Licensing Agreement

News   Sep 10, 2014

 
Allergopharma and S-TARget Conclude Licensing Agreement
 
 
 

RELATED ARTICLES

Protein Curbs Obesity Through Our Gut Bacteria

News

Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.

READ MORE

Additional Evidence Shows HPV Vaccine is Safe

News

Further evidence has been generated to demonstrate the safety of the life-saving bivalent HPV vaccine.

READ MORE

UK-India Project Combats Infections Threat with Diagnostics

News

A £3 million interdisciplinary research project is to address the growing threat of drug-resistant infections in India.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE